Literature DB >> 23917793

Thrombotic microangiopathy: eculizumab for atypical haemolytic uraemic syndrome: what next?

Fadi Fakhouri1, Véronique Frémeaux-Bacchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23917793     DOI： 10.1038/nrneph.2013.150

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  4 in total

Review 1.  Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Authors:  Julien Zuber; Fadi Fakhouri; Lubka T Roumenina; Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

2.  Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.

Authors:  M Le Quintrec; J Zuber; B Moulin; N Kamar; M Jablonski; A Lionet; V Chatelet; C Mousson; G Mourad; F Bridoux; E Cassuto; C Loirat; E Rondeau; M Delahousse; V Frémeaux-Bacchi
Journal:  Am J Transplant       Date:  2013-01-28       Impact factor: 8.086

3.  Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Authors:  C M Legendre; C Licht; P Muus; L A Greenbaum; S Babu; C Bedrosian; C Bingham; D J Cohen; Y Delmas; K Douglas; F Eitner; T Feldkamp; D Fouque; R R Furman; O Gaber; M Herthelius; M Hourmant; D Karpman; Y Lebranchu; C Mariat; J Menne; B Moulin; J Nürnberger; M Ogawa; G Remuzzi; T Richard; R Sberro-Soussan; B Severino; N S Sheerin; A Trivelli; L B Zimmerhackl; T Goodship; C Loirat
Journal:  N Engl J Med       Date:  2013-06-06       Impact factor: 91.245

4.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

Authors:  Véronique Fremeaux-Bacchi; Fadi Fakhouri; Arnaud Garnier; Frank Bienaimé; Marie-Agnès Dragon-Durey; Stéphanie Ngo; Bruno Moulin; Aude Servais; François Provot; Lionel Rostaing; Stéphane Burtey; Patrick Niaudet; Georges Deschênes; Yvon Lebranchu; Julien Zuber; Chantal Loirat
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-10       Impact factor: 8.237
  4 in total
  3 in total

Review 1.  The renaissance of complement therapeutics.

Authors:  Daniel Ricklin; Dimitrios C Mastellos; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

2.  Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis.

Authors:  Maria L Gonzalez Suarez; Charat Thongprayoon; Michael A Mao; Napat Leeaphorn; Tarun Bathini; Wisit Cheungpasitporn
Journal:  J Clin Med       Date:  2019-06-27       Impact factor: 4.241

3.  A novel approach to immunoapheresis of C3a/C3 and proteomic identification of associates.

Authors:  Wolfgang Winnicki; Peter Pichler; Karl Mechtler; Richard Imre; Ines Steinmacher; Gürkan Sengölge; Daniela Knafl; Georg Beilhack; Ludwig Wagner
Journal:  PeerJ       Date:  2019-12-16       Impact factor: 2.984
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.